Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sana Biotechnology (SANA – Research Report) and Integra Lifesciences (IART – Research Report).
Sana Biotechnology (SANA)
JMP Securities analyst Reni Benjamin downgraded Sana Biotechnology to Hold today. The company’s shares closed last Monday at $3.76, close to its 52-week low of $2.92.
According to TipRanks.com, Benjamin ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Sana Biotechnology is a Moderate Buy with an average price target of $12.67.
See today’s best-performing stocks on TipRanks >>
Integra Lifesciences (IART)
In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on Integra Lifesciences, with a price target of $35.00. The company’s shares closed last Monday at $24.12.
According to TipRanks.com, Turkaly has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Integra Lifesciences has an analyst consensus of Hold, with a price target consensus of $23.50.
Read More on SANA:
